Randomized clinical study to evaluate the efficacy of Shuddh Shilajit and Maansyadi Kashaya in the management of Aavrit Vyan w.s.r. to Essential Hypertension

Ayurvedic and Unani Tibbia College and Hospital0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年5月29日

试验速览

暂无简介。

•1. Subject willing to participate and able to provide written informed consent.
•2. Patient diagnosed as stage-I Essential Hypertension would be selected for study on the basis of 8th JNC & WHO criteria.
•3. Subjects who are able to come for follow up on fixed visits.

•1. Already diagnosed cases of Cardiovascular disease/ Cerebrovascular disease/ Renal disease/ Hypertensive Retinopathy.
•2. Subjects with any unstable heart disease or known cases of MI, unstable angina or CHF.
•3. Patients with concurrent hepatic dysfunction (defined as AST and/or ALT >2times of the upper normal limit) or Renal dysfunction, uncontrolled pulmonary dysfunction (asthmatic and COPD subjects).
•4. Subjects with current or past malignancy.
•5. Subject of have recent history or who are currently known to abuse of alcohol or drugs.
•6. Subjects suffering from major systemic illness neccessitating long term drug treatment(rheumatoid arthritis, psyco-neuro-endocrinal disorders, Tb, AIDS).
•7. Pregnant/lactating women.
•8. Subject on systemic or local steroids, oral contraceptive pills or estrogen replacement therapy.
•9. Subjects having hypersensitivity to any of the trial drug.
•10. Subjects who have completed participation in any other clinical trial during the past six (06) months.

发起方

Ayurvedic and Unani Tibbia College and Hospital